These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9371627)

  • 1. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony.
    Leroux C; Issel CJ; Montelaro RC
    J Virol; 1997 Dec; 71(12):9627-39. PubMed ID: 9371627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies.
    Leroux C; Craigo JK; Issel CJ; Montelaro RC
    J Virol; 2001 May; 75(10):4570-83. PubMed ID: 11312327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus.
    Lichtenstein DL; Issel CJ; Montelaro RC
    J Virol; 1996 Jun; 70(6):3346-54. PubMed ID: 8648664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype.
    Howe L; Leroux C; Issel CJ; Montelaro RC
    J Virol; 2002 Nov; 76(21):10588-97. PubMed ID: 12368301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic and biological variation in equine infectious anemia virus Rev correlates with variable stages of clinical disease in an experimentally infected pony.
    Belshan M; Baccam P; Oaks JL; Sponseller BA; Murphy SC; Cornette J; Carpenter S
    Virology; 2001 Jan; 279(1):185-200. PubMed ID: 11145901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralizing domain.
    Zheng YH; Sentsui H; Nakaya T; Kono Y; Ikuta K
    J Virol; 1997 Jul; 71(7):5031-9. PubMed ID: 9188568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication.
    Craigo JK; Leroux C; Howe L; Steckbeck JD; Cook SJ; Issel CJ; Montelaro RC
    J Gen Virol; 2002 Jun; 83(Pt 6):1353-1359. PubMed ID: 12029150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of an in vivo pathogenic molecular clone of equine infectious anemia virus.
    Cook RF; Leroux C; Cook SJ; Berger SL; Lichtenstein DL; Ghabrial NN; Montelaro RC; Issel CJ
    J Virol; 1998 Feb; 72(2):1383-93. PubMed ID: 9445039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease.
    Sponseller BA; Sparks WO; Wannemuehler Y; Li Y; Antons AK; Oaks JL; Carpenter S
    Virology; 2007 Jun; 363(1):156-65. PubMed ID: 17328936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus.
    Hammond SA; Li F; McKeon BM; Cook SJ; Issel CJ; Montelaro RC
    J Virol; 2000 Jul; 74(13):5968-81. PubMed ID: 10846078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anaemia virus during febrile episodes in an experimentally infected horse.
    Zheng YH; Nakaya T; Sentsui H; Kameoka M; Kishi M; Hagiwara K; Takahashi H; Kono Y; Ikuta K
    J Gen Virol; 1997 Apr; 78 ( Pt 4)():807-20. PubMed ID: 9129653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.
    Wang X; Wang S; Lin Y; Jiang C; Ma J; Zhao L; Lv X; Wang F; Shen R; Zhou J
    Virus Genes; 2011 Apr; 42(2):220-8. PubMed ID: 21369830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids.
    Harrold SM; Cook SJ; Cook RF; Rushlow KE; Issel CJ; Montelaro RC
    J Virol; 2000 Apr; 74(7):3112-21. PubMed ID: 10708426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation of envelope gp90 gene of equine infectious anemia virus isolated from an experimentally infected horse.
    Pang H; Kong XG; Sentsui H; Kono Y; Sugiura T; Hasegawa A; Akashi H
    J Vet Med Sci; 1997 Dec; 59(12):1089-95. PubMed ID: 9450237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease induction by virus derived from molecular clones of equine infectious anemia virus.
    Payne SL; Qi XM; Shao H; Dwyer A; Fuller FJ
    J Virol; 1998 Jan; 72(1):483-7. PubMed ID: 9420249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity.
    Lichtenstein DL; Rushlow KE; Cook RF; Raabe ML; Swardson CJ; Kociba GJ; Issel CJ; Montelaro RC
    J Virol; 1995 May; 69(5):2881-8. PubMed ID: 7707512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep sequencing and variant analysis of an Italian pathogenic field strain of equine infectious anaemia virus.
    Cappelli K; Cook RF; Stefanetti V; Passamonti F; Autorino GL; Scicluna MT; Coletti M; Verini Supplizi A; Capomaccio S
    Transbound Emerg Dis; 2017 Dec; 64(6):2104-2112. PubMed ID: 28299895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Equine Infectious Anemia Virus Long Terminal Repeat Quasispecies
    Wang XF; Liu Q; Wang YH; Wang S; Chen J; Lin YZ; Ma J; Zhou JH; Wang X
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29386282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long terminal repeat sequence variation on equine infectious anemia virus replication in vitro and in vivo.
    Lichtenstein DL; Craigo JK; Leroux C; Rushlow KE; Cook RF; Cook SJ; Issel CJ; Montelaro RC
    Virology; 1999 Oct; 263(2):408-17. PubMed ID: 10544113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evolution of the gp90 gene and consistently low plasma viral load during transient immune suppression demonstrate the safety of an attenuated equine infectious anemia virus (EIAV) vaccine.
    Ma J; Jiang C; Lin Y; Wang X; Zhao L; Xiang W; Shao Y; Shen R; Kong X; Zhou J
    Arch Virol; 2009; 154(5):867-73. PubMed ID: 19363668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.